Pediatric endoscopic pilonidal sinus treatment (PEPSiT): what we learned after a 3-year experience in the pediatric population - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Insights Gained from Three Years of Pediatric Endoscopic Treatment for Pilonidal Sinus Disease (PEPSiT)

  • By

  • Ciro Esposito

  • Ernesto Montaruli

  • Giuseppe Autorino

  • Mario Mendoza-Sagaon

  • Maria Escolino

  • May 22, 2021

Share

Objective:

To evaluate the effectiveness and safety of PEPSiT in the pediatric population and share specific technical insights related to the procedure.

Key Findings:
  • PEPSiT offers a minimally invasive approach with lower recurrence rates compared to traditional methods, with a reported recurrence rate of 9% in patients undergoing laser therapy.
  • Laser hair removal significantly reduces recurrence rates, with a 9% recurrence in patients undergoing laser therapy.
  • The standardized multistep protocol showed excellent results in managing PSD, with high patient satisfaction rates.
Interpretation:

PEPSiT is a safe and effective treatment for pediatric patients with pilonidal sinus disease, highlighting the critical role of pre-operative laser therapy in minimizing recurrence.

Limitations:
  • Retrospective design may introduce bias, potentially affecting the reliability of the outcomes.
  • Limited generalizability due to the specific patient population and treatment centers involved in the study.
Conclusion:

PEPSiT, combined with a multistep treatment protocol, represents a significant advancement in the management of pilonidal sinus disease in children, improving outcomes and patient satisfaction.

Original Source(s)

Related Content